Zacks Research Has Positive Outlook for EW Q1 Earnings
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Zacks Research boosted their Q1 2025 earnings estimates for shares of Edwards Lifesciences in a research report issued to clients and investors on Tuesday, March 4th. Zacks Research analyst R. Department now forecasts that the medical research company will post earnings per share of $0.58 for the ...
Publicado el: 2025-03-07 06:48:51
Autor: MarketBeat News, Fuente: etfdailynews
Compartir: 
